Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemophilia A With Anti Factor VIII”

15 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 15 of 15 results

Large-scale testing (Phase 3)Looking for participantsNCT05611801
What this trial is testing

A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B

Who this might be right for
Hemophilia AHemophilia B
Pfizer 100
Large-scale testing (Phase 3)Study completedNCT00851721
What this trial is testing

Efficacy and Safety Study of Prophylactic Versus On-Demand Treatment With Feiba NF in Subjects With Hemophilia A or B and a High Titer Inhibitor

Who this might be right for
Hemophilia A or B With InhibitorsHemophilia AHemophilia B
Baxalta now part of Shire 52
Post-approval studies (Phase 4)Study completedNCT00002386
What this trial is testing

Effect of Indinavir Plus Two Other Anti-HIV Drugs on Blood Clotting in HIV-Positive Males With Hemophilia

Who this might be right for
HIV InfectionsHemophilia A
Merck Sharp & Dohme LLC 55
Large-scale testing (Phase 3)Looking for participantsNCT05145127
What this trial is testing

Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors

Who this might be right for
Hemophilia AHemophilia B
Pfizer 245
Large-scale testing (Phase 3)Study completedNCT00375323
What this trial is testing

Recombinant Factor VIIa (NovoSeven) on Restoring Coagulation Activation

Who this might be right for
Hemophilia A
Medical University of Vienna
Early research (Phase 1)Study completedNCT00618579
What this trial is testing

Effects of LMWH in Healthy Subjects Treated With TB-402 and Effects of TB-402 in Healthy Subjects Treated With Warfarin

Who this might be right for
Healthy
ThromboGenics 15
Not applicableStudy completedNCT05173129
What this trial is testing

Posture Analysis for Patients With Haemophilia

Who this might be right for
HemophiliaPostural; DefectMuscle Disorder
Cukurova University 44
Large-scale testing (Phase 3)Study completedNCT03938792
What this trial is testing

Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B

Who this might be right for
Hemophilia AHemophilia B
Pfizer 189
Early research (Phase 1)WithdrawnNCT03996486
What this trial is testing

Study to Test the Safety of an Investigational Drug Given Repeatedly to Adult Men With Severe Hemophilia

Who this might be right for
Hemophilia
Bayer
Early research (Phase 1)Study completedNCT00612417
What this trial is testing

Effect of Recombinant FVIII in Healthy Male Subjects Treated With TB-402

Who this might be right for
Healthy
ThromboGenics 12
Not applicableLooking for participantsNCT05802836
What this trial is testing

Dynamics of the Anti-factor VIII Antibody Signature During Treatment With Emicizumab

Who this might be right for
Severe Hemophilia ASevere Hemophilia A With InhibitorSevere Hemophilia A Without Inhibitor
Christoph Königs 100
Large-scale testing (Phase 3)Ended earlyNCT00306670
What this trial is testing

Trial of Rituximab Versus Oral Cyclophosphamide to Eradicate or Suppress Autoimmune Anti-Factor VIII Antibodies in Acquired Hemophilia A

Who this might be right for
Hemophilia A
Georgetown University 2
Post-approval studies (Phase 4)Ended earlyNCT03204539
What this trial is testing

INdividualized ITI Based on Fviii(ATE) Protection by VWF

Who this might be right for
Hemophilia A With InhibitorHemophilia A
University of California, Davis 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT04684940
What this trial is testing

Safety, Tolerability, and Efficacy Study of Valoctocogene Roxaparvovec in Hemophilia A With Active or Prior Inhibitors

Who this might be right for
Hemophilia A With InhibitorHemophilia A With Anti Factor VIII
BioMarin Pharmaceutical 10
Large-scale testing (Phase 3)Study completedNCT00868530
What this trial is testing

Study Evaluating On-Demand Treatment Of Xyntha In Chinese Subjects

Who this might be right for
Hemophilia A
Pfizer 53